Stage I Multiple Myeloma Treatment (IFM-01-04).
Latest Information Update: 16 Apr 2024
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 11 Apr 2024 Status changed from active, no longer recruiting to completed.
- 23 Mar 2012 Planned end date changed from 1 Nov 2009 to 1 Nov 2012 as reported by ClinicalTrials.gov.
- 23 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.